Fidia Advances GGHL-Backed Convertible Bond Plan, Lifts Share Capital

Fidia Spa ( (IT:FDA) ) just unveiled an announcement.

Fidia S.p.A. has issued and placed with Global Growth Holding Limited the sixth tranche of its reserved convertible bond with attached warrants, comprising 25 bonds for a nominal €250,000 and 12,500,000 new warrants exercisable at €0.02 per share over 60 months. GGHL has also converted four bonds from the fifth tranche at €0.01 per share, resulting in the issuance of 4,000,000 new shares directly admitted to trading, bringing total POC subscriptions to €1.5 million.

Following this latest conversion, the capital increase linked to the POC has reached €1.25 million, with 25 bonds still outstanding and unconverted, and 31,458,000 POC‑related warrants in circulation and not exercised. As a result, Fidia’s share capital will rise by €40,000 to €11,097,761.90, and the total number of shares will increase to 84,542,927, underscoring the ongoing dilution for existing shareholders as the company continues to tap GGHL’s financing to support its operations and strategic positioning in its niche industrial markets.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high‑performance integrated milling systems. Its solutions, including numerical controls, high‑speed milling machines and CAM software for complex shapes, are used primarily in the automotive mould sector and the aerospace industry, where it covers the entire milling process from programming to finished part.

Average Trading Volume: 2,374,058

Technical Sentiment Signal: Strong Sell

Current Market Cap: €785.1K

For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.